Loading…
Based on limited metadata, this warning letter was issued to NingBo Huize Commodity Co., Ltd., a company involved in drug manufacturing or distribution, on August 2, 2019. Without access to the full letter text or subject line details, the specific nature of the violations cannot be determined from the available information. The letter falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided. To understand the precise compliance issues and required corrective actions, the complete warning letter would need to be reviewed.